Outcome | No malignancy (480) | Malignancy history > 5 years Group A (47) | Malignancy history < 5 years Group B (61) | Concurrent/incident malignancy Group C (52) | p-Value A vs C |
---|---|---|---|---|---|
Death | 230 (48%) | 19 (40.4%) | 26 (42.6%) | 25 (48.1%) | 0.44 |
Malignancy death | 0/111 | 1/12 (8.3%) | 5/14 (35.7%) | 5/14 (35.7%) | 0.17a |
CVD death | 53/111 (47.7%) | 1/12 (8.3%) | 3/14 (21.4%) | 3/14 (21.4%) | 0.59a |
ESRD | 131 (27.3%) | 13 (27.7%) | 17 (27.9%) | 15 (28.8%) | 0.89 |
RRT | 72 (15%) | 11 (23.4%) | 9 (14.8%) | 8 (15.4%) | 0.31 |
Renal transplants | 18 (13.7%) | 1/13 (7.7%) | 1/17 (5.9%) | 2/15 (13.3%) | 1.00a |